Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Issues related to the following bills: H.R. 1, One Big Beautiful Bill - Subtitle D (Health), Part 1 (Medicaid), S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; H.R. 3160/S.1553, the PREVAIL Act; H.R. 3152/S.1546, the PERA Act
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2025 · third_quarter · Q3
Issues related to the following bills: oBig Beautiful Bill (HR 1) oDrug Competition Enhancement Act (S.1040) oAffordable Prescriptions for Patients Act (S.1041) oStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act (S.1095) oPreserve Access to Affordable Generics and Biosimilars Act (S.1096) oPromoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R.3160/S.1553): oPatent Eligibility Restoration (PERA) Act (H.R.3152/S.1546) oPrescription Drug Price Relief Act (S.1818) oEnd Price Gouging for Medications Act (S.1753) oFair Prescription Drug Prices for Americans Act (S.1218)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Issues related to the following bills: oBig Beautiful Bill (HR 1) oDrug Competition Enhancement Act (S.1040) oAffordable Prescriptions for Patients Act (S.1041) oStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act (S.1095) oPreserve Access to Affordable Generics and Biosimilars Act (S.1096) oPromoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R.3160/S.1553): oPatent Eligibility Restoration (PERA) Act (H.R.3152/S.1546) oPrescription Drug Price Relief Act (S.1818) oEnd Price Gouging for Medications Act (S.1753) oFair Prescription Drug Prices for Americans Act (S.1218)
Patent Eligibility Restoration Act of 2025
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Issues related to the following bills: oBig Beautiful Bill (HR 1) oDrug Competition Enhancement Act (S.1040) oAffordable Prescriptions for Patients Act (S.1041) oStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act (S.1095) oPreserve Access to Affordable Generics and Biosimilars Act (S.1096) oPromoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R.3160/S.1553): oPatent Eligibility Restoration (PERA) Act (H.R.3152/S.1546) oPrescription Drug Price Relief Act (S.1818) oEnd Price Gouging for Medications Act (S.1753) oFair Prescription Drug Prices for Americans Act (S.1218)
Patent Eligibility Restoration Act of 2025
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Issues related to the following bills: H.R. 1, One Big Beautiful Bill - Subtitle D (Health), Part 1 (Medicaid), S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; H.R. 3160/S.1553, the PREVAIL Act; H.R. 3152/S.1546, the PERA Act
Issues related to the following bills: oBig Beautiful Bill (HR 1) oDrug Competition Enhancement Act (S.1040) oAffordable Prescriptions for Patients Act (S.1041) oStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act (S.1095) oPreserve Access to Affordable Generics and Biosimilars Act (S.1096) oPromoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R.3160/S.1553): oPatent Eligibility Restoration (PERA) Act (H.R.3152/S.1546) oPrescription Drug Price Relief Act (S.1818) oEnd Price Gouging for Medications Act (S.1753) oFair Prescription Drug Prices for Americans Act (S.1218)
Issues related to the following bills: H.R. 1, One Big Beautiful Bill - Subtitle D (Health), Part 1 (Medicaid), S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; H.R. 3160/S.1553, the PREVAIL Act; H.R. 3152/S.1546, the PERA Act
Issues related to the following bills: S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; and a to-be-introduced bill on insulin copays in line with The INSULIN Act of 2023 (S. 1269) and Affordable Insulin Now Act of 2023 (S. 954)
Issues related to the following bills: oBig Beautiful Bill (HR 1) oDrug Competition Enhancement Act (S.1040) oAffordable Prescriptions for Patients Act (S.1041) oStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act (S.1095) oPreserve Access to Affordable Generics and Biosimilars Act (S.1096) oPromoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R.3160/S.1553): oPatent Eligibility Restoration (PERA) Act (H.R.3152/S.1546) oPrescription Drug Price Relief Act (S.1818) oEnd Price Gouging for Medications Act (S.1753) oFair Prescription Drug Prices for Americans Act (S.1218)
Issues related to the following bills: H.R. 1, One Big Beautiful Bill - Subtitle D (Health), Part 1 (Medicaid), S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; H.R. 3160/S.1553, the PREVAIL Act; H.R. 3152/S.1546, the PERA Act
Affordable Prescriptions for Patients Act
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Issues related to the following bills: H.R. 1, One Big Beautiful Bill - Subtitle D (Health), Part 1 (Medicaid), S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; H.R. 3160/S.1553, the PREVAIL Act; H.R. 3152/S.1546, the PERA Act
Affordable Prescriptions for Patients Act
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Issues related to the following bills: oBig Beautiful Bill (HR 1) oDrug Competition Enhancement Act (S.1040) oAffordable Prescriptions for Patients Act (S.1041) oStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act (S.1095) oPreserve Access to Affordable Generics and Biosimilars Act (S.1096) oPromoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R.3160/S.1553): oPatent Eligibility Restoration (PERA) Act (H.R.3152/S.1546) oPrescription Drug Price Relief Act (S.1818) oEnd Price Gouging for Medications Act (S.1753) oFair Prescription Drug Prices for Americans Act (S.1218)
Affordable Prescriptions for Patients Act
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Issues related to the following bills: S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; and a to-be-introduced bill on insulin copays in line with The INSULIN Act of 2023 (S. 1269) and Affordable Insulin Now Act of 2023 (S. 954)
Issues related to the following bills: oBig Beautiful Bill (HR 1) oDrug Competition Enhancement Act (S.1040) oAffordable Prescriptions for Patients Act (S.1041) oStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act (S.1095) oPreserve Access to Affordable Generics and Biosimilars Act (S.1096) oPromoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R.3160/S.1553): oPatent Eligibility Restoration (PERA) Act (H.R.3152/S.1546) oPrescription Drug Price Relief Act (S.1818) oEnd Price Gouging for Medications Act (S.1753) oFair Prescription Drug Prices for Americans Act (S.1218)
Issues related to the following bills: H.R. 1, One Big Beautiful Bill - Subtitle D (Health), Part 1 (Medicaid), S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; H.R. 3160/S.1553, the PREVAIL Act; H.R. 3152/S.1546, the PERA Act
Issues related to the following bills: S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; and a to-be-introduced bill on insulin copays in line with The INSULIN Act of 2023 (S. 1269) and Affordable Insulin Now Act of 2023 (S. 954)
Preserve Access to Affordable Generics and Biosimilars Act
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Issues related to the following bills: S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; and a to-be-introduced bill on insulin copays in line with The INSULIN Act of 2023 (S. 1269) and Affordable Insulin Now Act of 2023 (S. 954)
Preserve Access to Affordable Generics and Biosimilars Act
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Issues related to the following bills: oBig Beautiful Bill (HR 1) oDrug Competition Enhancement Act (S.1040) oAffordable Prescriptions for Patients Act (S.1041) oStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act (S.1095) oPreserve Access to Affordable Generics and Biosimilars Act (S.1096) oPromoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R.3160/S.1553): oPatent Eligibility Restoration (PERA) Act (H.R.3152/S.1546) oPrescription Drug Price Relief Act (S.1818) oEnd Price Gouging for Medications Act (S.1753) oFair Prescription Drug Prices for Americans Act (S.1218)
Preserve Access to Affordable Generics and Biosimilars Act
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Issues related to the following bills: H.R. 1, One Big Beautiful Bill - Subtitle D (Health), Part 1 (Medicaid), S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; H.R. 3160/S.1553, the PREVAIL Act; H.R. 3152/S.1546, the PERA Act
Patent Eligibility Restoration Act of 2025
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Issues related to the following bills: oBig Beautiful Bill (HR 1) oDrug Competition Enhancement Act (S.1040) oAffordable Prescriptions for Patients Act (S.1041) oStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act (S.1095) oPreserve Access to Affordable Generics and Biosimilars Act (S.1096) oPromoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R.3160/S.1553): oPatent Eligibility Restoration (PERA) Act (H.R.3152/S.1546) oPrescription Drug Price Relief Act (S.1818) oEnd Price Gouging for Medications Act (S.1753) oFair Prescription Drug Prices for Americans Act (S.1218)
Patent Eligibility Restoration Act of 2025
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Issues related to the following bills: H.R. 1, One Big Beautiful Bill - Subtitle D (Health), Part 1 (Medicaid), S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; H.R. 3160/S.1553, the PREVAIL Act; H.R. 3152/S.1546, the PERA Act
Issues related to the following bills: H.R. 1, One Big Beautiful Bill - Subtitle D (Health), Part 1 (Medicaid), S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; H.R. 3160/S.1553, the PREVAIL Act; H.R. 3152/S.1546, the PERA Act
Issues related to the following bills: oBig Beautiful Bill (HR 1) oDrug Competition Enhancement Act (S.1040) oAffordable Prescriptions for Patients Act (S.1041) oStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act (S.1095) oPreserve Access to Affordable Generics and Biosimilars Act (S.1096) oPromoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R.3160/S.1553): oPatent Eligibility Restoration (PERA) Act (H.R.3152/S.1546) oPrescription Drug Price Relief Act (S.1818) oEnd Price Gouging for Medications Act (S.1753) oFair Prescription Drug Prices for Americans Act (S.1218)
Issues related to the following bills: oBig Beautiful Bill (HR 1) oDrug Competition Enhancement Act (S.1040) oAffordable Prescriptions for Patients Act (S.1041) oStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act (S.1095) oPreserve Access to Affordable Generics and Biosimilars Act (S.1096) oPromoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R.3160/S.1553): oPatent Eligibility Restoration (PERA) Act (H.R.3152/S.1546) oPrescription Drug Price Relief Act (S.1818) oEnd Price Gouging for Medications Act (S.1753) oFair Prescription Drug Prices for Americans Act (S.1218)
Prescription Drug Price Relief Act of 2025
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Issues related to the following bills: oBig Beautiful Bill (HR 1) oDrug Competition Enhancement Act (S.1040) oAffordable Prescriptions for Patients Act (S.1041) oStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act (S.1095) oPreserve Access to Affordable Generics and Biosimilars Act (S.1096) oPromoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R.3160/S.1553): oPatent Eligibility Restoration (PERA) Act (H.R.3152/S.1546) oPrescription Drug Price Relief Act (S.1818) oEnd Price Gouging for Medications Act (S.1753) oFair Prescription Drug Prices for Americans Act (S.1218)
Fair Prescription Drug Prices for Americans Act
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Issues related to the following bills: oBig Beautiful Bill (HR 1) oDrug Competition Enhancement Act (S.1040) oAffordable Prescriptions for Patients Act (S.1041) oStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act (S.1095) oPreserve Access to Affordable Generics and Biosimilars Act (S.1096) oPromoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R.3160/S.1553): oPatent Eligibility Restoration (PERA) Act (H.R.3152/S.1546) oPrescription Drug Price Relief Act (S.1818) oEnd Price Gouging for Medications Act (S.1753) oFair Prescription Drug Prices for Americans Act (S.1218)
Issues related to the following bills: S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; and a to-be-introduced bill on insulin copays in line with The INSULIN Act of 2023 (S. 1269) and Affordable Insulin Now Act of 2023 (S. 954)
Issues related to the following bills: S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; and a to-be-introduced bill on insulin copays in line with The INSULIN Act of 2023 (S. 1269) and Affordable Insulin Now Act of 2023 (S. 954)
Elijah E. Cummings Lower Drug Costs Now Act
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Build Back Better Act (H.R.5376); Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Insulin Affordability for All Act (no bill number)
Elijah E. Cummings Lower Drug Costs Now Act
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Affordable Insulin for All Act (H.R.4158); Emergency Access to Insulin Act (no bill number in current session)
Elijah E. Cummings Lower Drug Costs Now Act
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Affordable Insulin for All Act (H.R.4158); Emergency Access to Insulin Act (no bill number in current session)
Elijah E. Cummings Lower Drug Costs Now Act
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Build Back Better Act (H.R.5376); Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Insulin Affordability for All Act (no bill number)
Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Affordable Insulin for All Act (H.R.4158); Emergency Access to Insulin Act (no bill number in current session)
Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Affordable Insulin for All Act (H.R.4158); Emergency Access to Insulin Act (no bill number in current session)
Build Back Better Act (H.R.5376); Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Insulin Affordability for All Act (no bill number)
Build Back Better Act (H.R.5376); Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Insulin Affordability for All Act (no bill number)
2025 · second_quarter · Q2
Issues related to the following bills: H.R. 1, One Big Beautiful Bill - Subtitle D (Health), Part 1 (Medicaid), S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; H.R. 3160/S.1553, the PREVAIL Act; H.R. 3152/S.1546, the PERA Act
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2025 · first_quarter · Q1
Issues related to the following bills: S. 1040, regarding product hopping; S. 1041, regarding patent evergreening; S. 1095, the Stop STALLING Act; S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act; and a to-be-introduced bill on insulin copays in line with The INSULIN Act of 2023 (S. 1269) and Affordable Insulin Now Act of 2023 (S. 954)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2024 · fourth_quarter · Q4
General issues regarding legislation related to healthcare.
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2021 · fourth_quarter · Q4
Build Back Better Act (H.R.5376); Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Insulin Affordability for All Act (no bill number)
Build Back Better Act (H.R.5376); Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Insulin Affordability for All Act (no bill number)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2021 · third_quarter · Q3
Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Affordable Insulin for All Act (H.R.4158); Emergency Access to Insulin Act (no bill number in current session)
Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Affordable Insulin for All Act (H.R.4158); Emergency Access to Insulin Act (no bill number in current session)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2021 · second_quarter · RA
Issues related to insulin & diabetes related health care, access to medicines, and related patents.
Issues related to insulin & diabetes related health care, access to medicines, and related patents.
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2021 · second_quarter · RA
Issues related to insulin & diabetes related health care, access to medicines, and related patents.
Issues related to insulin & diabetes related health care, access to medicines, and related patents.